High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study

scientific article

High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1044724370
P356DOI10.1186/AR3842
P932PMC publication ID3446493
P698PubMed publication ID22584154
P5875ResearchGate publication ID224957004

P50authorLeo A.B. JoostenQ89547374
P2093author name stringJaap Fransen
Piet van Riel
Anton Stalenhoef
Calin D Popa
Elke Arts
Heidi Lemmers
P2860cites workImprovement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis.Q33436848
Abnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritisQ33687843
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritisQ34182804
Effect of HDL composition and particle size on the resistance of HDL to the oxidationQ34198872
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studiesQ34496492
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studiesQ34889152
Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled studyQ34897630
Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritisQ35036976
Sex hormones and rheumatoid arthritisQ35172062
High-density lipoprotein heterogeneity and function in reverse cholesterol transportQ35546972
Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritisQ35553035
Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990sQ35554980
High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritisQ36183213
Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritisQ36204149
Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysisQ36463025
Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular eventsQ36952948
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisQ36955395
Prospective study of coronary heart disease vs. HDL2, HDL3, and other lipoproteins in Gofman's Livermore CohortQ37205985
Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actionsQ37415092
Effects of estrogens and progestins on high density lipoproteinsQ40212312
Menopause and coronary heart disease. The Framingham StudyQ42072645
The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be betterQ42935046
A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarctionQ43603017
Disease activity as a risk factor for myocardial infarction in rheumatoid arthritisQ43836845
Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular diseaseQ43929837
HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of riskQ44248636
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients?Q45235877
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE InvestigationQ46433523
Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patientsQ46477622
Ultracentrifugation in swinging-bucket and fixed-angle rotors evaluated for isolation and determination of high-density lipoprotein subfractions HDL2 and HDL3.Q50929571
Influence of age and menopause on serum lipids and lipoproteins in healthy women.Q51061075
The effect of fasting status on the determination of low-density and high-density lipoprotein cholesterol.Q51585466
Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarctionQ67720879
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatmentQ67720940
HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish menQ70212233
Mortality in a cohort of Norwegian patients with rheumatoid arthritis followed from 1977 to 1992Q73560184
Clinical significance of plasma HDL subfractions (HDL2, HDL3) in patients with peripheral arterial disease (PAD) in the Greek populationQ77351864
Lipid profiles in untreated patients with rheumatoid arthritisQ78139431
Survival in rheumatoid arthritis: a population-based analysis of trends over 40 yearsQ78794833
Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic diseaseQ79354392
Short-term adalimumab therapy improves endo-thelial function in patients with rheumatoid arthritis refractory to infliximabQ79996729
Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosisQ81412936
Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapyQ82734935
P433issue3
P921main subjectrheumatoid arthritisQ187255
HDL cholesterolQ67322514
P304page(s)R116
P577publication date2012-05-14
P1433published inArthritis Research and TherapyQ15757229
P1476titleHigh-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
P478volume14

Reverse relations

cites work (P2860)
Q36238859Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals
Q92464675Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment
Q35222947Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study
Q38115132Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
Q58576589Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease
Q37209902Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study
Q38287565Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?
Q36162860Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process
Q36054251Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis.
Q35257568Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis
Q37729358State of the Art on Functional Virgin Olive Oils Enriched with Bioactive Compounds and Their Properties
Q36241682[Rheumatoid arthritis].